EURONEXT:BOTHE
Bone Therapeutics
- Stock
Last Close
0.29
26/10 15:35
Volume Today
1.39M
Avg: 201.58K
PE Ratio
−0.26
PFCF: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Sep '14 | Dec '14 | Jun '21 | Dec '21 | Jun '22 | Sep '22 | Dec '22 | Mar '23 | Jun '23 | Sep '23 | Dec '23 | Mar '24 | Jun '24 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
net income | -1.35M - | -1.12M 16.75% | -1.88M 67.50% | -6.07M 222.81% | -6.85M 12.86% | -3.21M 53.12% | -757K 76.44% | -757K 0% | -10.42M 1,276.68% | -20.84M 100% | -3.97M 80.96% | -7.93M 100% | 247.50K 103.12% | 247.50K 0% | |
depreciation and amortization | 111K - | 92K 17.12% | 66K 28.26% | 64K 3.03% | 70K 9.38% | 114K 62.86% | 27.50K 75.88% | 27.50K 0% | 50.50K 83.64% | 101K 100% | 71K 29.70% | 142K 100% | 53K 62.68% | 53K 0% | |
deferred income tax | |||||||||||||||
stock based compensation | -31.50K - | -31.50K 0% | |||||||||||||
change in working capital | 255K - | -154K 160.39% | 977K 734.42% | -105K 110.75% | 667K 735.24% | -2.19M 428.94% | 15K 100.68% | 15K 0% | -17K 213.33% | 458K 2,794.12% | 44.50K 90.28% | 1.23M 2,666.29% | -62.50K 105.08% | -62.50K 0% | |
accounts receivables | -139K - | -485K 248.92% | 549K 213.20% | 15K 97.27% | 15K 0% | -17K 213.33% | -34K 100% | 44.50K 230.88% | 89K 100% | -62.50K 170.22% | -62.50K 0% | ||||
inventory | |||||||||||||||
accounts payables | -2.05M - | 1.37M 166.68% | -2.74M 300.37% | 492K - | 1.14M - | -827K - | |||||||||
other working capital | 2.09M - | -217K 110.40% | |||||||||||||
other non cash items | 224K - | -345K 254.02% | 1.23M 455.65% | 1.89M 54.28% | -1.59M 184.15% | 974K 161.14% | -115K 111.81% | -115K 0% | 9.42M 8,293.91% | 18.09M 91.92% | 3.08M 82.96% | 4.06M 31.73% | -623.50K 115.36% | -623.50K 0% | |
net cash provided by operating activities | -759K - | -1.53M 101.58% | 389K 125.42% | -6.54M 1,781.23% | -6.96M 6.50% | -6.74M 3.22% | -829.50K 87.69% | -829.50K 0% | -965K 16.34% | -1.94M 101.35% | -770K 60.37% | -1.55M 101.95% | -417K 73.18% | -417K 0% | |
investments in property plant and equipment | -836K - | -765K 8.49% | -649K 15.16% | -81K 87.52% | -126K 55.56% | -44K 65.08% | -2.50K 94.32% | -2.50K 0% | -6K 140% | -13K 116.67% | 6K 146.15% | ||||
acquisitions net | 978K - | 978K 0% | 3K - | 3K - | |||||||||||
purchases of investments | |||||||||||||||
sales maturities of investments | -13K - | ||||||||||||||
other investing activites | -6K - | 2K 133.33% | 2K 0% | 500 - | 500 0% | 9.50K 1,800% | 17K 78.95% | -6.50K 138.24% | |||||||
net cash used for investing activites | -855K - | -763K 10.76% | -647K 15.20% | -81K 87.48% | -126K 55.56% | -44K 65.08% | 976K 2,318.18% | 976K 0% | 3.50K 99.64% | 7K 100% | -500 107.14% | -1K 100% | |||
debt repayment | -375K - | -203K 45.87% | -2.00M - | -7.56M 278.67% | -164K 97.83% | -325K - | -400K - | -953K - | |||||||
common stock issued | 450K - | 913K - | 500K - | ||||||||||||
common stock repurchased | |||||||||||||||
dividends paid | |||||||||||||||
other financing activites | 755K - | 2.61M 245.30% | 10.10M 287.42% | 3.01M - | 1.14M 62.28% | 591K 47.93% | 591K 0% | 298K 49.58% | -82K 127.52% | 569.50K 794.51% | -56K 109.83% | 766.50K 1,468.75% | 766.50K 0% | ||
net cash used provided by financing activities | 380K - | 2.40M 532.63% | 10.10M 320.13% | -2.01M 119.93% | 10.59M 625.93% | 1.24M 88.31% | 591K 52.26% | 591K 0% | 298K 49.58% | 609K 104.36% | 569.50K 6.49% | 1.15M 102.63% | 766.50K 33.58% | 766.50K 0% | |
effect of forex changes on cash | -1K - | -2.12M - | |||||||||||||
net change in cash | -1.23M - | 111K 109.00% | 9.84M 8,765.77% | -8.63M 187.73% | 3.50M 140.49% | -5.55M 258.67% | 737.50K 113.30% | 737.50K 0% | -663.50K 189.97% | -3.44M 419.07% | -201K 94.16% | -402K 100% | 349.50K 186.94% | 699K 100% | |
cash at beginning of period | 3.67M - | 1.74M - | 14.65M 743.78% | 6.01M 58.94% | 9.51M 58.13% | 371K 96.10% | 3.96M - | 519K - | 117K - | ||||||
cash at end of period | 2.44M - | 111K 95.45% | 11.58M 10,329.73% | 6.01M 48.05% | 9.51M 58.13% | 3.96M 58.33% | 1.11M 72.03% | 737.50K 33.47% | -663.50K 189.97% | 519K 178.22% | -201K 138.73% | 117K 158.21% | 349.50K 198.72% | 816K 133.48% | |
operating cash flow | -759K - | -1.53M 101.58% | 389K 125.42% | -6.54M 1,781.23% | -6.96M 6.50% | -6.74M 3.22% | -829.50K 87.69% | -829.50K 0% | -965K 16.34% | -1.94M 101.35% | -770K 60.37% | -1.55M 101.95% | -417K 73.18% | -417K 0% | |
capital expenditure | -836K - | -765K 8.49% | -649K 15.16% | -81K 87.52% | -126K 55.56% | -44K 65.08% | -2.50K 94.32% | -2.50K 0% | -6K 140% | -13K 116.67% | 6K 146.15% | ||||
free cash flow | -1.59M - | -2.29M 43.89% | -260K 88.67% | -6.62M 2,446.54% | -7.09M 7.10% | -6.79M 4.32% | -832K 87.74% | -832K 0% | -971K 16.71% | -1.96M 101.44% | -764K 60.94% | -1.55M 103.53% | -417K 73.18% | -417K 0% |
All numbers in EUR (except ratios and percentages)